Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2022, 4(11); doi: 10.25236/IJFM.2022.041106.

Overview of etiology and pathogenesis of cerebral arteriosclerotic vertigo and research progress in the treatment of traditional Chinese medicine

Author(s)

Kaijun Zhou1, Zhihong Yang2, Yue Zhou1, Yu Kang1

Corresponding Author:
Zhihong Yang
Affiliation(s)

1Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China

2The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China

Abstract

Nowadays, the incidence of cerebral arteriosclerosis is increasing year by year, and vertigo is the most common concomitant symptom, which seriously affects the quality of life of patients. A number of clinical studies have confirmed that TCM treatment of cerebral arteriosclerosis has the characteristic of high efficiency, short course of treatment and low adverse reactions. This paper mainly summarizes the etiology and pathogenesis arteriosclerotic vertigo and reviews the relevant research progress of TCM in the treatment of arteriosclerotic vertigo in the past decade, and presents personal outlook and insights on the future treatment of cerebral arteriosclerosis by TCM.

Keywords

Cerebral Arteriosclerosis; Vertigo; Etiology and Pathogenesis; Traditional Chinese Medicine Treatment; Research Progress

Cite This Paper

Kaijun Zhou, Zhihong Yang, Yue Zhou, Yu Kang. Overview of etiology and pathogenesis of cerebral arteriosclerotic vertigo and research progress in the treatment of traditional Chinese medicine. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 11: 37-43. https://doi.org/10.25236/IJFM.2022.041106.

References

[1] Ma Yongqi. Clinical Study on 41 Cases of Cerebral Arteriosclerotic Vertigo Treated by Phlegm and Blood Stasis [J]. Jiangsu Traditional Chinese Medicine, 2011, 43 (05): 30-31.

[2] Li Yanhong, Huang Wen. Professor Huang Wen's Experience in Treating Cerebral Arteriosclerosis [J]. Yunnan Journal of Traditional Chinese Medicine, 2014, 35 (02): 4-5.

[3] Wang Li, Zhuang Yanhong, He Jiancheng, Liang Jianqing. Modern literature research on common syndromes and syndrome factors of cerebral arteriosclerosis [J]. Chinese Journal of Traditional Chinese Medicine, 2016, 31 (03): 808-811.

[4] Yuan Xingyi. Efficacy of Huayu Tongnao Decoction in the Treatment of Cerebral Arteriosclerosis (Phlegm-blood Stasis Type) and Its Effect on Cerebral Hemodynamics [J]. Sichuan Journal of Traditional Chinese Medicine, 2017, 35 (10): 104-107.

[5] Zhang Fan. Correlation between plasma CRP, Lp-PLA2, sCD40L and atherosclerotic vascular vertigo [D]. Hebei North University, 2018.

[6] Zhang Li, Zhang Shupei, Lu Jingjing. Effect of Vessel Fukang Capsule as an Adjunct to Atorvastatin Calcium Tablets and Aspirin in the Treatment of Patients with Cerebral Arteriosclerosis [J]. Henan Medical Research, 2022, 31 (13): 2448-2451.

[7] Wan Xiaolin, Wang Junli, Feng Li, Chen Guohua. Discussion of Vertigo in Traditional Chinese Medicine [J]. Asia-Pacific Traditional Medicine, 2016, 12 (13): 64-65.

[8] Pang Min. Academic Thought and Clinical Experience of Hong Zhiping, [M]. Liaoning Science and Technology Press, 2019.10:59-61 

[9] Qiu Haili, Zhou Zhiwei, Sun Guiming, Huang Pengzhan. TCM Syndrome Differentiation Treatment of 60 Cases of Senile Cerebral Arteriosclerotic Vertigo [J]. Chinese and Foreign Medical Treatment, 2015, 34 (11): 156-157.

[10] Jia Huidi. 60 Cases of senile cerebral atherosclerotic vertigo treated with TCM syndrome differentiation [J]. Electronic Journal of Cardiovascular Diseases of Integrated Traditional Chinese and Western Medicine, 2020, 8 (18): 181, 186.

[11] Zhang Shaolei. TCM syndrome differentiation in the treatment of 60 cases of senile cerebral atherosclerotic vertigo [J]. Henan Traditional Chinese Medicine, 2015, 35 (11): 2642-2643.

[12] Wang Shihe. Observation on the therapeutic effect of dialectical treatment of 62 cases of senile cerebral arteriosclerotic vertigo with traditional Chinese medicine [J]. World Latest Medical Information (Electronic Version), 2013 (12): 249-249, 248.

[13] Zhu Meiju, Guo Zhenqiu, Zhao Fujin. Correlation between serum TNF-α, NO and kidney deficiency and blood stasis syndrome in patients with cerebral arteriosclerotic vertigo [J]. Chinese Journal of Basic Medicine of Traditional Chinese Medicine, 2000, (10): 27-30.

[14] Zhang Yan. To analyze the medication regularity of Dr. Yang Zhihong in the treatment of cerebral arteriosclerotic vertigo based on the TCM inheritance platform [D]. Shaanxi University of Traditional Chinese Medicine, 2018.

[15] Quan Yiheng, Shangguan Chen Hong, Chen Chen Chen. Progress in the pharmacological effects of phenolic components in Gastrodia elata Blume on cardiovascular and cerebrovascular diseases [J]. Chinese Herbal Medicine, 2022, 53 (14): 4582-4592.

[16] Zhu Yao, Liu Qi, Gu Ning, Shi Aiwu. Progress in the research of the active ingredients of Chuanxiong and their cardiovascular system protective effects [J]. Shi Zhen Guo Yi Sinopharm, 2016, 27 (07): 1701-1704.

[17] Hu Pengyi, Liu Dan, Zheng Qin, Tang Yu, Guo Yuanyuan, Yang Ming, Yue Pengfei, Wang Yaqi, Wu Zhenfeng. Effect and mechanism of active components of Chuanxiong on transmembrane transport of gastrodin on MDCK-MDR1 cells [J]. Chinese Journal of Pharmacy, 2017, 52 (14): 1234-1240.

[18] Hu Xianrong, Wang Shengjiang. Retrospective analysis of 60 cases of senile cerebral arteriosclerotic vertigo treated with dialectical therapy of traditional Chinese medicine [J]. Journal of Medical Forum, 2015, 36 (03): 122-123.

[19] Wan Shijun. Clinical study on TCM syndrome differentiation in the treatment of senile cerebral arteriosclerotic vertigo [J]. Medical Information, 2016, 29 (26): 246-246.

[20] Li Hanmei. Comparison of the efficacy of Xuesaitong soft capsules and Ginkgo biloba ketone ester dripping pills in the treatment of cerebral arteriosclerotic vertigo [J]. Chinese Geriatric Health Care Medicine, 2018, 16 (03): 105-106.

[21] Shen Yanfang, Li Weiping, Du Jumei, Yan Jiang, Liang Fengjun, Wang Ru, Ding Tianhong. Clinical study of ginkgo biloba ketone ester dripping pills in the treatment of vertigo caused by cerebral arteriosclerosis [J]. Modern Chinese Medicine, 2022, 42 (05): 107-110.

[22] Wang Chunyan, Wu Dongmei. Correlation between the risk of cerebral infarction and blood homocysteine levels [J]. China Practical Medicine, 2015, 25 (10): 44-45.

[23] Wang Jijuan, Wang Weihua. Ginkgo biloba extract dripping pills on cerebral arteriosclerosis vertigo with hyperhomocysteinemia [J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2021, 38 (03): 459-463.

[24] Wei Liang. Clinical study of vertigo tablets in the treatment of cerebral arteriosclerotic vertigo [J]. Health Care Guidelines, 2018 (5): 42. 

[25] Wang Bin, Liu Yuelan, Zhu Na Lin, Tian Qing. Efficacy of Tiaoshen Xingnao acupuncture in patients with cerebral arteriosclerotic vertigo and its effect on neurological function [J]. Yunnan Journal of Traditional Chinese Medicine, 2020, 41 (05): 75-76.

[26] Jin Ying. Observation on the effect of acupoint injection of scopolamine and vitamin B6 in the treatment of elderly patients with cerebral arteriosclerotic vertigo [J]. Chinese Rural Medicine, 2017, 24 (02): 60-61.

[27] Li Dongyan. Observation on the application of Xuefu Zhuyu Decoction in the treatment of vertigo caused by cerebral arteriosclerosis [J]. Chinese Medical Guidelines, 2020, 18 (16): 191-192.

[28] Yang Dongfeng, Li Chuanxia, Wang Yiyi. Efficacy observation of Qiangli Dingxuan Tablets combined with Flunarizine in the treatment of cerebral arteriosclerotic vertigo [J]. Modern Drugs and Clinical, 2020, 35 (08): 1553-1556.

[29] Yang Qian, Fan Weibing, Cai Li, Li Yixin, Mao Xinfa. Clinical efficacy of Qiangli Dingxuan Tablets combined with Flunarizine in the treatment of cerebral arteriosclerotic vertigo and its effect on cerebral blood flow [J]. Journal of Clinical Rational Drug Use, 2022, 15 (27): 24-27.

[30] Shang Jianhua. Efficacy of Yangxueqingnao Granule combined with Flunarizine in the Treatment of Cerebral Arteriosclerotic Vertigo and its Effect on Cerebral Blood Flow [J]. Thrombosis and Hemostasis, 2021, 27 (05): 732-733 + 736.

[31] Liu Wei, Zhao Libo, Yang Yufei, Fu Hongjuan. To investigate the clinical study of flunarizine combined with Xuesaitong in the treatment of cerebral arteriosclerotic dizziness [J]. China Rural Health, 2017, (02): 13 + 15.

[32] Lu Shaowei. Clinical Observation on the Treatment of Cerebral Arteriosclerosis Vertigo with Integrated Traditional Chinese and Western Medicine [J]. China Health Standard Management, 2016, 7 (07): 150-151.

[33] Tang Kun. Effect of Guipi Decoction on Cerebral Atherosclerotic Vertigo [J]. Contemporary Medicine Forum, 2015, 13 (20): 22-23.

[34] Song Xuan, Yang Zhihong. Clinical Observation on the Treatment of Vertigo in Cerebral Arteriosclerosis with Integrated Traditional Chinese and Western Medicine [J]. Medical Information, 2015 (49): 415-415.